Today's IPO for TCR2 Therapeutics Inc. (NASDAQ: TCRR) opened for trading at $15.15 after pricing 5,000,000 shares of common stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE